The news roundup for the week ending 21 October 2016.
Opportunities abound for entrepreneurs
Sydney University has put $1m into a student-founded accelerator as Phoenix University opened its innovation hub RedFlint and Harvard University’s Jeff Bussgang unveiled a $2.5m fund.
Pain assessment technology developer ePat is set to list on the Australian Stock Exchange, providing an exit to Curtin University.
Based on research conducted at MIT Media Lab, Oblong Industries is developing spatial, gesture-enabled technologies and has now added Utimco to its shareholders.
George Baxter has been appointed chief executive of Edinburgh Research and Innovation, joining from Nottingham University.
Zimmerman calls time on Utimco job
Bruce Zimmerman has resigned as chief executive of Utimco, the investment company of University of Texas system.
MapD directs In-Q-Tel to series A
In-Q-Tel has been revealed as an investor in MIT spinout MapD’s series A round, which raised $12m in April from Verizon, Nvidia, Alphabet and others.
Veritas finds truth in $30m series B
Lilly Asia Ventures has returned for genetic testing startup Veritas Genetics’ series B round, where it was joined by Jiangsu Simcere Pharmaceutical.
Naver’s NHN Investment is backing Celleron Therapeutics, an Oxford University spinout that is preparing to launch phase 2 trials for a personalised cancer treatment.
Investors shine on Oxford PV series C
Oxford Photovoltaics has secured an initial $10.7m in series C capital from unnamed investors as it gears up for commercialisation.
Deal net: 17 – 21 October 2016
The Global University Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.
